NADAC acquisition cost data for PROBENECID 500 MG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00527136701 | $0.5540 | 2022-12-21 | Rx |
| 00527136710 | $0.5540 | 2022-12-21 | Rx |
| 00591534701 | $0.5540 | 2022-12-21 | Rx |
| 00591534710 | $0.5540 | 2022-12-21 | Rx |
| 00527136701 | $0.5540 | 2022-12-21 | Rx |
| 00527136710 | $0.5540 | 2022-12-21 | Rx |
| 00591534701 | $0.5540 | 2022-12-21 | Rx |
| 00591534710 | $0.5540 | 2022-12-21 | Rx |
Generic: Probenecid | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $5.2M | 74,377 | 19,171 | $0.7159 |
| 2020 | $5.7M | 71,742 | 18,516 | $0.7856 |
| 2021 | $7.3M | 67,547 | 17,797 | $1.04 |
| 2022 | $6.9M | 61,505 | 16,251 | $1.10 |
| 2023 | $6.3M | 58,647 | 15,132 | $1.04 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $770.6K | 5,805 | 1,684 |
| Texas | $310.3K | 3,263 | 897 |
| Florida | $289.6K | 3,122 | 888 |
| Michigan | $271.5K | 2,529 | 652 |
| Ohio | $267.3K | 2,576 | 637 |
| New York | $263.0K | 2,549 | 681 |
| Pennsylvania | $243.3K | 2,277 | 568 |
| Illinois | $235.4K | 2,478 | 640 |
| North Carolina | $226.4K | 2,139 | 548 |
| Georgia | $215.7K | 2,055 | 535 |
| Washington | $206.7K | 1,661 | 430 |
| Colorado | $194.6K | 1,323 | 371 |
| Wisconsin | $182.7K | 1,620 | 386 |
| Virginia | $171.8K | 1,453 | 384 |
| Tennessee | $166.4K | 1,726 | 457 |
| Indiana | $147.9K | 1,389 | 368 |
| Oregon | $139.2K | 1,123 | 312 |
| Missouri | $128.9K | 1,209 | 297 |
| Minnesota | $120.6K | 905 | 253 |
| Massachusetts | $119.8K | 1,295 | 351 |
| South Carolina | $109.9K | 935 | 285 |
| Arizona | $105.9K | 937 | 263 |
| Iowa | $96.9K | 789 | 187 |
| Maryland | $90.7K | 832 | 237 |
| Kentucky | $89.5K | 919 | 230 |
| Alabama | $88.6K | 1,138 | 253 |
| New Jersey | $88.1K | 846 | 237 |
| Connecticut | $83.2K | 593 | 150 |
| Arkansas | $72.2K | 943 | 203 |
| Louisiana | $68.5K | 850 | 202 |
| Mississippi | $62.7K | 802 | 178 |
| Oklahoma | $60.5K | 616 | 161 |
| Kansas | $55.5K | 649 | 152 |
| Hawaii | $55.4K | 556 | 167 |
| New Mexico | $51.9K | 428 | 123 |
| Nevada | $48.2K | 457 | 135 |
| Idaho | $46.7K | 474 | 123 |
| Utah | $39.7K | 281 | 86 |
| Montana | $38.2K | 333 | 86 |
| West Virginia | $34.8K | 370 | 101 |
| Nebraska | $32.3K | 321 | 84 |
| Vermont | $30.7K | 224 | 50 |
| Maine | $29.6K | 320 | 92 |
| New Hampshire | $26.5K | 252 | 74 |
| Delaware | $16.5K | 152 | 48 |
| South Dakota | $16.5K | 228 | 43 |
| Wyoming | $15.4K | 167 | 45 |
| Rhode Island | $13.0K | 133 | 36 |
| North Dakota | $11.5K | 150 | 36 |
| Puerto Rico | $8.9K | 258 | 58 |
| Alaska | $8.5K | 68 | 24 |
| District of Columbia | $8.4K | 96 | 25 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.